191 related articles for article (PubMed ID: 17597537)
1. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.
Barends M; Jaidee A; Khaohirun N; Singhasivanon P; Nosten F
Malar J; 2007 Jun; 6():81. PubMed ID: 17597537
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia.
Mairet-Khedim M; Nardella F; Khim N; Kim S; Kloeung N; Ke S; Kauy C; Eam R; Khean C; Pellet A; Leboulleux D; Leang R; Ringwald P; Barale JC; Leroy D; Menard D; Witkowski B
J Antimicrob Chemother; 2019 Nov; 74(11):3240-3244. PubMed ID: 31518407
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
5. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
[TBL] [Abstract][Full Text] [Related]
7. A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.
McCarthy JS; Rückle T; Djeriou E; Cantalloube C; Ter-Minassian D; Baker M; O'Rourke P; Griffin P; Marquart L; Hooft van Huijsduijnen R; Möhrle JJ
Malar J; 2016 Sep; 15(1):469. PubMed ID: 27624471
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium vivax susceptibility to ferroquine.
Leimanis ML; Jaidee A; Sriprawat K; Kaewpongsri S; Suwanarusk R; Barends M; Phyo AP; Russell B; Renia L; Nosten F
Antimicrob Agents Chemother; 2010 May; 54(5):2228-30. PubMed ID: 20308387
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Plasmodium falciparum resistance to ferroquine (SSR97193) in field isolates and in W2 strain under pressure.
Daher W; Biot C; Fandeur T; Jouin H; Pelinski L; Viscogliosi E; Fraisse L; Pradines B; Brocard J; Khalife J; Dive D
Malar J; 2006 Feb; 5():11. PubMed ID: 16464254
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.
Daher W; Pelinski L; Klieber S; Sadoun F; Meunier V; Bourrié M; Biot C; Guillou F; Fabre G; Brocard J; Fraisse L; Maffrand JP; Khalife J; Dive D
Drug Metab Dispos; 2006 Apr; 34(4):667-82. PubMed ID: 16415117
[TBL] [Abstract][Full Text] [Related]
12. Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum.
Pradines B; Fusai T; Daries W; Laloge V; Rogier C; Millet P; Panconi E; Kombila M; Parzy D
J Antimicrob Chemother; 2001 Aug; 48(2):179-84. PubMed ID: 11481286
[TBL] [Abstract][Full Text] [Related]
13. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
[TBL] [Abstract][Full Text] [Related]
14. Ferroquine and its derivatives: new generation of antimalarial agents.
Wani WA; Jameel E; Baig U; Mumtazuddin S; Hun LT
Eur J Med Chem; 2015 Aug; 101():534-51. PubMed ID: 26188909
[TBL] [Abstract][Full Text] [Related]
15. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
Sante; 2008; 18(1):43-7. PubMed ID: 18684691
[TBL] [Abstract][Full Text] [Related]
16. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
[TBL] [Abstract][Full Text] [Related]
18. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
[TBL] [Abstract][Full Text] [Related]
19. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Nqoro X; Aderibigbe BA
Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021
[TBL] [Abstract][Full Text] [Related]
20. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.
Dive D; Biot C
ChemMedChem; 2008 Mar; 3(3):383-91. PubMed ID: 17806092
[No Abstract] [Full Text] [Related]
[Next] [New Search]
